Walmart Says US Manufacturing Keeps Supply Chain ‘Flexible and Dynamic'

Core Insights - Walmart is increasing its investment in U.S. manufacturing, including a new beef processing plant in Kansas that will create 600 jobs and a partnership with USAntibiotics to produce amoxicillin domestically [2][3] - Nearly two-thirds of products sold by Walmart are made, grown, or assembled in the U.S., highlighting the company's commitment to domestic production [2] - Pfizer is also planning additional investments in U.S. manufacturing, benefiting from a three-year exemption from pharmaceutical-specific tariffs as part of a deal with the Trump administration [3][4] Group 1: Walmart's Initiatives - Walmart's investment in a new beef processing plant in Kansas will create 600 jobs [2] - The partnership with USAntibiotics aims to produce products like amoxicillin in the U.S. [2] - Approximately 66% of products sold by Walmart are made, grown, or assembled in the U.S. [2] Group 2: Broader Industry Context - Pfizer's CEO emphasized the need for regulatory changes to improve productivity and innovation in biotechnology and pharmaceuticals [4] - Treasury Secretary Scott Bessent noted that Trump's policies have signaled that "America's open for business," encouraging domestic operations [4][5] - A report indicated that 5.9% of U.S. firms with at least $1 billion in annual revenues replaced foreign suppliers with domestic ones in mid-May [5] - Among companies that had not replaced suppliers, fewer than 30% expressed interest in doing so in May, a decrease from 36.7% the previous month [6]